Literature DB >> 35137243

Complementary proteome and glycoproteome access revealed through comparative analysis of reversed phase and porous graphitic carbon chromatography.

Daniel G Delafield1, Hannah N Miles2, Yuan Liu2, William A Ricke2,3,4, Lingjun Li5,6.   

Abstract

Continual developments in instrumental and analytical techniques have aided in establishing rigorous connections between protein glycosylation and human illness. These illnesses, such as various forms of cancer, are often associated with poor prognoses, prompting the need for more comprehensive characterization of the glycoproteome. While innovative instrumental and computational strategies have largely benefited glycoproteomic analyses, less attention is given to benefits gained through alternative, optimized chromatographic techniques. Porous graphitic carbon (PGC) chromatography has gained considerable interest in glycomics research due to its mobile phase flexibility, increased retention of polar analytes, and improved structural elucidation at higher temperatures. PGC has yet to be systematically compared against or in tandem with standard reversed phase liquid chromatography (RPLC) in high-throughput bottom-up glycoproteomic experiments, leaving the potential benefits unexplored. Performing comparative analysis of single and biphasic separation regimes at a range of column temperatures illustrates complementary advantages for each method. PGC separation is shown to selectively retain shorter, more hydrophilic glycopeptide species, imparting higher average charge, and exhibiting greater microheterogeneity coverage for identified glycosites. Additionally, we demonstrate that liquid-phase separation of glycopeptide isomers may be achieved through both single and biphasic PGC separations, providing a means towards facile, multidimensional glycopeptide characterization. Beyond this, we demonstrate how utilization of multiple separation regimes and column temperatures can aid in profiling the glycoproteome in tumorigenic and aggressive prostate cancer cells. RAW MS proteomic and glycoproteomic datasets have been deposited to the ProteomeXchange Consortium via the PRIDE partner repository with the dataset identifier PXD024196 (10.6019/PXD024196) and PXD024195, respectively.
© 2022. Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Glycopeptides; Glycoproteomics; Mass spectrometry; Porous graphitic carbon; Proteomics

Mesh:

Substances:

Year:  2022        PMID: 35137243      PMCID: PMC9246830          DOI: 10.1007/s00216-022-03934-7

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.478


  26 in total

1.  T cells from induced and spontaneous models of SLE recognize a common T cell epitope on β2-glycoprotein I.

Authors:  David Salem; Rebecca Subang; Masataka Kuwana; Jerrold S Levine; Joyce Rauch
Journal:  Cell Mol Immunol       Date:  2018-03-23       Impact factor: 11.530

2.  Inhibition of HER2-Positive Breast Cancer Growth by Blocking the HER2 Signaling Pathway with HER2-Glycan-Imprinted Nanoparticles.

Authors:  Yueru Dong; Wei Li; Zikuan Gu; Rongrong Xing; Yanyan Ma; Qi Zhang; Zhen Liu
Journal:  Angew Chem Int Ed Engl       Date:  2019-06-28       Impact factor: 15.336

3.  Quantitative Effects of O-Linked Glycans on Protein Folding.

Authors:  Patrick K Chaffey; Xiaoyang Guan; Xinfeng Wang; Yuan Ruan; Yaohao Li; Suzannah G Miller; Amy H Tran; Theo N Koelsch; Lomax F Pass; Zhongping Tan
Journal:  Biochemistry       Date:  2017-08-15       Impact factor: 3.162

Review 4.  Glycosylation in immune cell trafficking.

Authors:  Markus Sperandio; Christian A Gleissner; Klaus Ley
Journal:  Immunol Rev       Date:  2009-07       Impact factor: 12.988

5.  Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone.

Authors:  Robert Sackstein; Jasmeen S Merzaban; Derek W Cain; Nilesh M Dagia; Joel A Spencer; Charles P Lin; Roland Wohlgemuth
Journal:  Nat Med       Date:  2008-01-13       Impact factor: 53.440

6.  MicroRNAs regulating mucin type O-glycan biosynthesis and transforming growth factor β signaling pathways in nasal mucosa of patients with chronic rhinosinusitis with nasal polyps in Northern China.

Authors:  Lijia Xuan; Ge Luan; Yue Wang; Feng Lan; Xu Zhang; Yun Hao; Ming Zheng; Xiangdong Wang; Luo Zhang
Journal:  Int Forum Allergy Rhinol       Date:  2018-10-31       Impact factor: 3.858

7.  Deciphering the Functions of O-GlcNAc Glycosylation in the Brain: The Role of Site-Specific Quantitative O-GlcNAcomics.

Authors:  John W Thompson; Alexander W Sorum; Linda C Hsieh-Wilson
Journal:  Biochemistry       Date:  2018-07-02       Impact factor: 3.162

8.  Soluble glycoprotein VI, a specific marker of platelet activation is increased in the plasma of subjects with seropositive rheumatoid arthritis.

Authors:  John R Stack; Anne Madigan; Laura Helbert; Eimear Dunne; Elizabeth E Gardiner; Robert K Andrews; Roisin Finan; Elizabeth Smyth; Dermot Kenny; Geraldine M McCarthy
Journal:  PLoS One       Date:  2017-11-15       Impact factor: 3.240

9.  N-Glycan-dependent protein folding and endoplasmic reticulum retention regulate GPI-anchor processing.

Authors:  Yi-Shi Liu; Xin-Yu Guo; Tetsuya Hirata; Yao Rong; Daisuke Motooka; Toshihiko Kitajima; Yoshiko Murakami; Xiao-Dong Gao; Shota Nakamura; Taroh Kinoshita; Morihisa Fujita
Journal:  J Cell Biol       Date:  2017-12-18       Impact factor: 10.539

10.  Novel model of secreted human tau protein reveals the impact of the abnormal N-glycosylation of tau on its aggregation propensity.

Authors:  Yelena Losev; Ashim Paul; Moran Frenkel-Pinter; Malak Abu-Hussein; Isam Khalaila; Ehud Gazit; Daniel Segal
Journal:  Sci Rep       Date:  2019-02-19       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.